首页 > 资讯 > 糖尿病患者血糖波动管理专家共识

糖尿病患者血糖波动管理专家共识

泰然健康网
2024-12-19 04:51

利益冲突

【声明】本共识代表《糖尿病患者血糖波动管理专家共识》编写组的立场。在缺乏随机对照试验或临床实践问题特殊说明的情况下，参加讨论的专家使用的是他们的判断和经验。制订本共识是为临床提供指导和参考，而不是对所有个体患者的规定，不能代替临床医生的判断。

[1]

. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes[J]. Diabetes Care, 2016, 39( 4): 502- 510. .

[2]

?krhaJ, ?oupalJ, ?krhaJ, et al. Glucose variability, HbA1c and microvascular complications[J]. Rev Endocr Metab Disord, 2016, 17( 1): 103- 110. .

[3]

KohnertKD, AugsteinP, ZanderE, et al. Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents[J]. Diabetes Care, 2009, 32( 6): 1058- 1062. .

[4]

CandidoR. Which patients should be evaluated for blood glucose variability？[J] Diabetes Obes Metab, 2013, 15( Suppl 2): 9- 12. .

[5]

CerielloA, ColagiuriS. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations[J]. Diabet Med, 2008, 25( 10): 1151- 1156. .

[6]

SuG, MiS, TaoH, et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes[J]. Cardiovasc Diabetol, 2011, 10: 19. .

[7]

SuG, MiSH, TaoH, et al. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction[J]. Diabetes Care, 2013, 36( 4): 1026- 1032. .

[8]

CoutinhoM, GersteinHC, WangY, et al. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95, 783 individuals followed for 12.4 years[J]. Diabetes Care, 1999, 22( 2): 233- 240.

[9]

JinSM, KimTH, OhS, et al. Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring[J]. Diabet Med, 2015, 32( 2): 274- 279. .

[10]

HsuCR, ChenYT, SheuWH. Glycemic variability and diabetes retinopathy: a missing link[J]. J Diabetes Complications, 2015, 29( 2): 302- 306. .

[11]

吕丽芳，王椿，刘关键，等. 自我血糖监测对预测糖调节异常者与糖尿病患者的日内血糖波动的价值[J]. 四川大学学报(医学版), 2011， 42( 1): 95- 100.

[12]

InchiostroS, CandidoR, CavalotF. How can we monitor glycaemic variability in the clinical setting？[J] Diabetes Obes Metab, 2013, 15( Suppl 2): 13- 16. .

[13]

JungHS. Clinical implications of glucose variability: Chronic complications of diabetes[J]. Endocrinol Metab (Seoul), 2015, 30( 2): 167- 174. .

[14]

中华医学会糖尿病学分会. 中国血糖监测临床应用指南(2015年版)[J]. 中华糖尿病杂志， 2015， 7( 10): 603- 613. .

[15]

喻明，周健，项坤三，等. 动态监测糖耐量正常者血糖水平的漂移变化[J]. 中华医学杂志， 2004，( 21): 1788- 1790. .

[16]

ZhengF, LuW, JiaC, et al. Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation[J]. Endocrine, 2010, 37( 1): 201- 208. .

[17]

WangC, LvL, YangY, et al. Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus[J]. Clin Endocrinol (Oxf), 2012, 76( 6): 810- 815. .

[18]

何利平，王椿，钟莉，等. 成都地区糖耐量正常者血糖水平变化的特征分析[J]. 四川大学学报(医学版), 2009， 40( 4): 704- 707. .

[19]

康怡，陆菊明，孙敬芳，等. 不同糖调节受损人群的血糖波动特征[J]. 中华医学杂志， 2009， 89( 10): 669- 672. .

[20]

TangX, LiS, WangY, et al. Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c[J]. Clin Chim Acta, 2016, 461: 146- 150. .

[21]

XiaJ, XuJ, LiB, et al. Association between glycemic variability and major adverse cardiovascular and cerebrovascular events (MACCE) in patients with acute coronary syndrome during 30-day follow-up[J]. Clin Chim Acta, 2017, 466: 162- 166. .

[22]

周健，贾伟平，喻明，等. 上海地区中国人餐后血糖状态的特征[J]. 中华医学杂志， 2006， 86( 14): 970- 975. .

[23]

BonoraE, CalcaterraF, LombardiS, et al. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control[J]. Diabetes Care, 2001, 24( 12): 2023- 2029.

[24]

黄敬泽，王健. 血糖波动对2型糖尿病患者血管内皮损伤的影响[J]. 中国老年学杂志， 2010， 30( 21): 3076- 3078. .

[25]

顾霖，陆宏红，项容. 血糖波动对2型糖尿病患者尿微量白蛋白排泄率的影响[J]. 牡丹江医学院学报， 2014，( 5): 49- 51.

[26]

Guideline for management of postmeal glucose in diabetes[J]. Diabetes Res Clin Pract, 2014, 103( 2): 256- 268. .

[27]

中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华内分泌代谢杂志， 2014， 30( 10): 893- 942. .

[28]

RavelliD, ZemaM, MellaM, et al. Benzoyl radicals from (hetero)aromatic aldehydes. Decatungstate photocatalyzed synthesis of substituted aromatic ketones[J]. Org Biomol Chem, 2010, 8( 18): 4158- 4164. .

[29]

CandidoR. Which patients should be evaluated for blood glucose variability？[J] Diabetes Obes Metab, 2013, 15( Suppl 2): 9- 12. .

[30]

BaoYQ, ZhouJ, ZhouM, et al. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes[J]. Clin Exp Pharmacol Physiol, 2010, 37( 5-6): 564- 568. .

[31]

李晓静，高政南，程丽静，等. 采用CGMS评价阿卡波糖对胰岛素治疗血糖波动的影响[J]. 中华内分泌代谢杂志， 2012， 28( 2): 140- 143. .

[32]

CopelandKC, SilversteinJ, MooreKR, et al. Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescents[J]. Pediatrics, 2013, 131( 2): 364- 382. .

[33]

陈莉明. 糖尿病特殊人群的血糖监测[J]. 中华糖尿病杂志， 2016， 8( 12): 709- 712. .

[34]

方福生，成晓玲，李志冰，等. 老年2型糖尿病患者血糖波动性别差异的病例对照研究[J]. 中国药物应用与监测， 2013，( 4): 193- 196. .

[35]

方福生，李志冰，成晓玲，等. 老年2型糖尿病患者血糖波动的影响因素[J]. 中华医学杂志， 2013， 93( 40): 3202- 3206. .

[36]

中国老年学学会老年医学会老年内分泌代谢专业委员会，老年糖尿病诊疗措施专家共识编写组. 老年糖尿病诊疗措施专家共识(2013年版)[J]. 中华内科杂志， 2014， 53( 3): 243- 251. .

[37]

International Diabetes Federation. Global Guideline for Managing Older People with Type 2 Diabetes[EB/OL]. https://www.idf.org/our-activities/advocacy-awareness/resources-and-tools/78:global-guideline-for-managing-older-people-with-type-2-diabetes.html, 2013.

[38]

中华医学会妇产科学分会产科学组，中华医学会围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南(2014)[J]. 中华妇产科杂志， 2014， 49( 8): 561- 569. .

[39]

中国医师协会内分泌代谢科医师分会. 2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版)[J]. 中华内分泌代谢杂志， 2016， 32( 6): 455- 460. .

[40]

高颖，杨光燃，周迎生，等. 心血管疾病合并糖尿病口服降糖药物应用专家共识[J]. 中华内科杂志， 2014， 53( 10): 833- 838. .

[41]

RydénL, GrantPJ, AnkerSD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)[J]. Eur Heart J, 2013, 34( 39): 3035- 3087. .